Skip to main content
. 2020 Feb 18;150(8):2041–2050. doi: 10.1093/jn/nxaa024

TABLE 3.

Characteristics of participants who consumed a low, medium, or high dose of intrinsically labeled casein1

T1 (n = 120) T2 (n = 120) T3 (n = 119)
Dose
 g 20 ± 1a 21 ± 2a 33 ± 7b
 g/kg BM 0.24 ± 0.01a 0.28 ± 0.02b 0.44 ± 0.07c
 g/kg LBM 0.31 ± 0.02a 0.36 ± 0.04b 0.55 ± 0.11c
Age, y 60 ± 21a 56 ± 24a 46 ± 25b
Men/women, n/n 120/0 120/0 119/0
Height, m 1.79 ± 0.07a 1.76 ± 0.07b 1.78 ± 0.07a,b
BM, kg 84.1 ± 5.4a 73.3 ± 6.7b 73.4 ± 9.4b
BMI, kg/m2 26.5 ± 2.1a 23.7 ± 2.3b 23.3 ± 2.8b
Fat, % 21.1 ± 4.0a 18.5 ± 4.9b 17.0 ± 5.0b
ALM, kg 27.6 ± 2.8a 25.2 ± 2.5b 27.0 ± 3.9a
LBM, kg 64.5 ± 4.8a 57.9 ± 4.2b 58.4 ± 7.0b
HbA1c, % 5.9 ± 0.9a 5.6 ± 0.4b 5.6 ± 0.4b
Plasma glucose, mmol/L
 Fasting 6.3 ± 1.9a 5.7 ± 0.8b 5.7 ± 0.7b
 2 h post–75-g oral-glucose 7.8 ± 4.7a 6.1 ± 2.4b 6.0 ± 1.5b
1

Values are means ± SDs. Labeled means (in a row) without a common letter differ, P < 0.05. Protein dose ranged from 0.20 to 0.25 g/kg BM for T1, 0.26 to 0.33 g/kg BM for T2, and 0.34 to 0.64 g/kg BM for T3. ALM, appendicular lean mass; BM, body mass; HbA1c, glycated hemoglobin; LBM, lean body mass; T, tertile.